Jcog0304
Webjcog0304 Kazuhiro Tanaka 1* , Gakuto Ogawa 2 , Junki Mizusawa 2 , Norifumi Naka 3 , Akira Kawai 4 , Mitsuru Takahashi 5 , Toru Hiruma 6 , Yoshihiro Matsumoto 7 , Hiroyuki Tsuchiya 8 , Robert Nakayama 9 , Hiroshi Hatano 10 , Makoto Emori 11 , WebJCOG0304 IFO/ADMによる補助化学療法phaseII 高悪性度非円形細胞軟部肉腫に対するIfosfamide、Adriamycin による 術前術後補助化学療法の第II 相臨床試験実施計画 …
Jcog0304
Did you know?
Web10 ago 2024 · Prospective comparison of various radiological response criteria and pathological response to preoperative chemotherapy and survival in operable high-grade soft tissue sarcomas in the Japan Clinical Oncology Group study JCOG0304. WebJCOG0304. e tumor was resected within 5 weeks from the last cycle of preoperative chemotherapy. Postopera-tively, two cycles of DOX and IFO were carried out at intervals of 3 weeks. Among the patients enrolled in JCOG0304 study, those whose pathological specimens of the maximum cross-sectional slice of the tumor were available after receiv-
Web6 set 2024 · Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304. Web23 gen 2024 · We referred to the JCOG0304 regimen, 10 which is a perioperative chemotherapy regimen originally reported to be effective for high-grade sarcomas (including synovial sarcomas) in the extremities. The original regimen is doxorubicin 30 mg/m 2 /day (days 1 and 2) + ifosfamide 2 g/m 2 /day (days 1–5), but in order to reduce the adverse …
Web10 ago 2024 · Response to preoperative chemotherapy. A total of 72 patients who suffered from operable high-grade STS in the extremities were enrolled in the JCOG0304 trial …
WebMethods: Using data and specimens from the patients who had registered in the Japan Clinical Oncology Group study, JCOG0304, a phase II trial evaluating the efficacy of perioperative chemotherapy with doxorubicin (DOX) and ifosfamide (IFO), we evaluated histological response to preoperative chemotherapy at the central review board.
Web20 apr 2009 · This phase II clinical trial aims to evaluate the efficacies and toxicities of pre- and postoperative chemotherapy with adriamycin plus ifosfamide on the patients with soft-tissue high-grade sarcomas. Patients who have operable, non-round cell soft-tissue sarcomas [French Federation of Cancer Center (FNCLCC) Grades 2 and 3] arising in the … jerga nicaraguaWeb26 mag 2024 · e22533 Background: STS are rare malignant tumors and relatively resistant against chemotherapy. We have previously reported 3-year follow-up on the efficacy results of perioperative chemotherapy with DXR and IFM for STS in the extremities (JCOG0304) in ASCO 2011 (abstract ID:#10078). In the present report, we analyzed 10-year follow-up … lamax speakerhttp://www.jcog.jp/document/s_0304.pdf jerga objetoWeb25 mag 2024 · Background: Our previous phase II study for high-grade soft tissue sarcomas (STS), JCOG0304, suggested long-term favorable effects of perioperative adriamycin … lamax s9 dual gps manualWeb23 mag 2012 · Methods All 70 eligible patients with STS in the extremities treated by perioperative chemotherapy in JCOG0304 were analyzed. Univariate and multivariate … lamax s9 dual rückfahrkameraWebJCOG0304, including the efficacy, safety, and correlation of outcomes with prognostic factors and radiological re-sponse [5–7]. In the present study, we analyzed the 10-year … jerga onomatopeyaWeb6 set 2024 · The study protocol of JCOG0304 was approved by the Protocol Review Committee of the Japan Clinical Oncology Group (JCOG) and was also approved by the Institutional Review Boards of each of the 27 participating institutions. Written informed consent was obtained from each patient before study enrollment. jerga mexicana